首页> 外国专利> 3-4--1--1H- MELK Novel 3-4-piperazin-1-ylbenzamido-1H-pyrazolopyridine derivatives or pharmaceutically acceptable salts thereof preparation method thereof and pharmaceutical composition for use in preventing or treating MELKmaternal embryonic leucine zipper kinase activity related diseases containing the same as an active ingredient

3-4--1--1H- MELK Novel 3-4-piperazin-1-ylbenzamido-1H-pyrazolopyridine derivatives or pharmaceutically acceptable salts thereof preparation method thereof and pharmaceutical composition for use in preventing or treating MELKmaternal embryonic leucine zipper kinase activity related diseases containing the same as an active ingredient

机译:3-4--1--1H-MELK新型3-4-哌嗪-1-基苯甲酰胺基-1H-吡唑并吡啶盐的制备方法和用于预防或治疗MELK的母体胚胎亮氨酸拉链激酶活性相关药物组合物含有与有效成分相同的疾病

摘要

The present invention relates to a 3-(4-(piperazin-1-yl)benzamido)-1H-pyrazolopyridine derivative or pharmaceutically acceptable salt thereof, a preparation method thereof, and a pharmaceutical composition for preventing or treating maternal embryonic leucine zipper kinase (MELK)-related diseases containing the same as an active ingredient. The 3-(4-(piperazin-1-yl)benzamido)-1H-pyrazolopyridine derivative according to the present invention has an excellent effect on inhibiting the expression of MELK, and can be usefully utilized for preventing or treating MELK-related diseases including types of cancer such as breast cancer, lung cancer, bladder cancer, lymphoma, polymorphism glioblastoma, cervical cancer, etc.;COPYRIGHT KIPO 2017
机译:本发明涉及3-(4-(哌嗪-1-基)苯甲酰胺基)-1H-吡唑并吡啶衍生物或其药学上可接受的盐,其制备方法以及用于预防或治疗母体胚胎亮氨酸拉链激酶的药物组合物(含有与MELK相关的疾病的有效成分。根据本发明的3-(4-(哌嗪-1-基)苯甲酰胺基)-1H-吡唑并吡啶衍生物具有优异的抑制MELK表达的作用,并且可有效地用于预防或治疗与MELK有关的疾病,包括乳腺癌,肺癌,膀胱癌,淋巴瘤,多态性胶质母细胞瘤,宫颈癌等癌症类型; COPYRIGHT KIPO 2017

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号